Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- SAR 19.06T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | SAR 35.9B | SAR 237.29 | 0.88% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SAR 30.3B | SAR 437.10 | 0.07% down | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SAR 18.2B | SAR 323.04 | 0.99% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SAR 30.5B | SAR 466.96 | 0.14% down | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SAR 32B | SAR 1,144.45 | 0.01% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | SAR 27B | SAR 193.72 | 0.01% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SAR 16.9B | SAR 101.50 | 0.37% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SAR 22.1B | SAR 1,105.49 | 0.31% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SAR 33.6B | SAR 353.40 | 0.43% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | SAR 29.2B | SAR 173.60 | 1.83% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SAR 16.7B | SAR 152.76 | 3.13% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | SAR 56.4B | SAR 289.69 | 0.56% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | SAR 17.3B | SAR 49.29 | 5.40% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | SAR 18.4B | SAR 105.91 | 1.38% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SAR 22.3B | SAR 341.79 | 0.90% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | SAR 18B | SAR 187.17 | 2.35% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | SAR 24.5B | SAR 361.63 | 0.09% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | SAR 18.9B | SAR 225.96 | 0.20% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SAR 36B | SAR 1,550.94 | 2.02% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | SAR 58.4B | SAR 910.22 | 0.81% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | SAR 27.7B | SAR 252.83 | 3.81% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SAR 22.8B | SAR 161.39 | 0.08% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | SAR 19.5B | SAR 463.06 | 1.74% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SAR 43.4B | SAR 223.90 | 2.02% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | SAR 14.6B | SAR 106.90 | 3.00% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | SAR 49.3B | SAR 98.54 | 1.62% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | SAR 98.1B | SAR 447.23 | 2.16% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | SAR 104.9B | SAR 144.84 | 0.25% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SAR 26.1B | SAR 496.67 | 2.60% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | SAR 11.7B | SAR 60.20 | 0.37% down | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | SAR 28.1B | SAR 358.22 | 0.41% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | SAR 31.6B | SAR 39.54 | 1.22% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | SAR 27.4B | SAR 313.40 | 1.77% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | SAR 66.4B | SAR 1,012.88 | 0.43% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | SAR 91.1B | SAR 2,138.16 | 2.41% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | SAR 127.5B | SAR 313.85 | 0.23% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SAR 76.9B | SAR 574.03 | 2.21% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | SAR 24.2B | SAR 594.96 | 0.57% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SAR 28B | SAR 80.46 | 1.56% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | SAR 88.5B | SAR 77.21 | 0.66% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | SAR 46.7B | SAR 56.06 | 1.05% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | SAR 185B | SAR 158.52 | 0.84% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | SAR 601.7B | SAR 105.57 | 1.14% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | SAR 458.7B | SAR 224.42 | 2.48% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | SAR 147.4B | SAR 256.34 | 0.50% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | SAR 370.5B | SAR 3,581.94 | 0.30% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | SAR 507B | SAR 1,999.66 | 0.21% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | SAR 118.6B | SAR 192.28 | 1.35% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | SAR 172.9B | SAR 1,513.55 | 2.36% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | SAR 676.8B | SAR 390.78 | 0.51% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | SAR 1.29T | SAR 524.05 | 2.55% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | SAR 1.91T | SAR 1,078.07 | 1.85% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | SAR 21.7B | SAR 31.92 | 1.39% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | SAR 652.9B | SAR 148.15 | 2.96% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | SAR 4.66T | SAR 5,225.97 | 1.58% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | SAR 367.2B | SAR 183.20 | 0.81% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | SAR 2.48T | SAR 1,031.56 | 1.32% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | SAR 425.9B | SAR 177.38 | 0.50% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | SAR 1.11T | SAR 586.58 | 1.73% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | SAR 1.04T | SAR 670.83 | 1.88% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | SAR 256.2B | SAR 80.18 | 1.22% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of SAR 19.06T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.